According to the World Health Organisation, antibiotic resistance is one of the biggest threats to global public health. A growing number of serious infections of such as pneumonia, tuberculosis, and gonorrhea are becoming harder to treat as the antibiotics used to treat them become less effective. Antibiotics are medicines that are used treat bacterial infections.
Antibiotic resistance occurs when the bacteria stops responding to the effects of the antibiotics and tends to become immune to them. This makes it more difficult to treat the particular viral disease. Although antibiotic resistance occurs naturally, the misuse of medicines is making this process faster. A new study, published in the Journal of Antimicrobial Chemotherapy, indicates another reason that may be increasing the risk of antibiotic resistance.
According to researchers, an antibacterial and anti-fungal agent called triclosan, found in toothpastes, soaps and detergents, can be blamed for it. The study shows that resistance to triclosan may also lead to resistance to a class of drugs called quinolones and therefore, triclosan exposure may encourage the growth of antibiotic resistant strains.

Surprisingly, while the use of triclosan has been prohibited in soaps, body washes and other topical products, it still exists in our toothpastes. It is added to prevent bacterial contamination and plaque build-up, but a lot of recent studies have shown that triclosan may disrupt the metabolism, cause hormonal problems in children and promote drug-resistant infections. Keeping this in mind, the use of triclosan in toothpastes is worrisome because the chemical can be easily absorbed in the bloodstream through the gums. The jury is till out on whether triclosan in toothpastes can be harmful for your health.
The study raises concerns about certain ingredients found in products that we use daily that are altering ecosystems and potentially promoting a selection of antibiotic resistant bacteria.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022